AU2019335515A1 - Systems and methods for microbiome analysis - Google Patents
Systems and methods for microbiome analysis Download PDFInfo
- Publication number
- AU2019335515A1 AU2019335515A1 AU2019335515A AU2019335515A AU2019335515A1 AU 2019335515 A1 AU2019335515 A1 AU 2019335515A1 AU 2019335515 A AU2019335515 A AU 2019335515A AU 2019335515 A AU2019335515 A AU 2019335515A AU 2019335515 A1 AU2019335515 A1 AU 2019335515A1
- Authority
- AU
- Australia
- Prior art keywords
- subject
- sample
- activity
- methods
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Data Mining & Analysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Databases & Information Systems (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862728035P | 2018-09-06 | 2018-09-06 | |
| US62/728,035 | 2018-09-06 | ||
| PCT/US2019/050102 WO2020051559A1 (en) | 2018-09-06 | 2019-09-06 | Systems and methods for microbiome analysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2019335515A1 true AU2019335515A1 (en) | 2021-04-29 |
Family
ID=69723304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019335515A Pending AU2019335515A1 (en) | 2018-09-06 | 2019-09-06 | Systems and methods for microbiome analysis |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210332418A1 (de) |
| EP (1) | EP3847273A4 (de) |
| AU (1) | AU2019335515A1 (de) |
| CA (1) | CA3112004A1 (de) |
| WO (1) | WO2020051559A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210398449A1 (en) | 2018-10-08 | 2021-12-23 | Naveen Jain | Methods for and compositions for determining food item recommendations |
| WO2020168015A1 (en) | 2019-02-12 | 2020-08-20 | Viome, Inc. | Personalizing food recommendations to reduce glycemic response |
| WO2021195604A2 (en) * | 2020-03-27 | 2021-09-30 | Viome, Inc. | Diagnostic for oral cancer |
| CN112712856A (zh) * | 2020-12-25 | 2021-04-27 | 北京群峰纳源健康科技有限公司 | 一种基于肠道菌群分析膳食结构的方法 |
| WO2022266266A1 (en) | 2021-06-15 | 2022-12-22 | Viome Life Sciences, Inc. | Methods and compositions for evaluating and treating blood glucose dysregulation |
| EP4303325A1 (de) | 2022-07-05 | 2024-01-10 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Verfahren zum bestimmen von bakteriellen metaboliten zur individualisierten ernährungseinstellung |
| WO2025096651A1 (en) * | 2023-11-01 | 2025-05-08 | Cipher Genetics, Inc. | Systems and methods for nutrigenomics and nutrigenetic analysis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150057574A1 (en) * | 2013-08-23 | 2015-02-26 | Elwha Llc | Selecting and Delivering Treatment Agents based on a Microbe Profile |
| US10325685B2 (en) * | 2014-10-21 | 2019-06-18 | uBiome, Inc. | Method and system for characterizing diet-related conditions |
| EP3386592A4 (de) * | 2015-12-09 | 2019-05-22 | Ubiome, Inc. | Verfahren und system zur charakterisierung mit clostridium difficile assoziierten erkrankungen |
| WO2018036503A1 (en) * | 2016-08-25 | 2018-03-01 | The Chinese University Of Hong Kong | Fecal bacterial markers for colorectal cancer |
| US20240127925A1 (en) * | 2021-02-03 | 2024-04-18 | Tata Consultancy Services Limited | Method and system for designing personalized therapeutics and diet based on functions of microbiome |
-
2019
- 2019-09-06 CA CA3112004A patent/CA3112004A1/en active Pending
- 2019-09-06 WO PCT/US2019/050102 patent/WO2020051559A1/en not_active Ceased
- 2019-09-06 US US17/273,463 patent/US20210332418A1/en active Pending
- 2019-09-06 EP EP19857515.1A patent/EP3847273A4/de active Pending
- 2019-09-06 AU AU2019335515A patent/AU2019335515A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3847273A4 (de) | 2022-06-08 |
| US20210332418A1 (en) | 2021-10-28 |
| WO2020051559A1 (en) | 2020-03-12 |
| EP3847273A1 (de) | 2021-07-14 |
| CA3112004A1 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210332418A1 (en) | Systems and methods for microbiome analysis | |
| Lim et al. | Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet | |
| Tang et al. | Screening of microbes associated with swine growth and fat deposition traits across the intestinal tract | |
| Solomon et al. | Protozoa populations are ecosystem engineers that shape prokaryotic community structure and function of the rumen microbial ecosystem | |
| Hou et al. | Differential fecal microbiota are retained in broiler chicken lines divergently selected for fatness traits | |
| Huber et al. | Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer | |
| Fart et al. | Differences in gut microbiome composition between senior orienteering athletes and community-dwelling older adults | |
| Afolayan et al. | Impact of a nomadic pastoral lifestyle on the gut microbiome in the Fulani living in Nigeria | |
| Borrello et al. | Dietary intake mediates ethnic differences in gut microbial composition | |
| Elokil et al. | Investigation of the impacts of antibiotic exposure on the diversity of the gut microbiota in chicks | |
| Fu et al. | Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience | |
| Carvalho et al. | Antimicrobial resistance genes and diversity of clones among faecal ESBL-producing Escherichia coli isolated from healthy and sick dogs living in Portugal | |
| Schreurs et al. | How the gut microbiome links to menopause and obesity, with possible implications for endometrial cancer development | |
| Ansari et al. | Lactobacillus probiotics improve vaginal dysbiosis in asymptomatic women | |
| US20220344003A1 (en) | Biomarkers for Age | |
| McCann et al. | Enterolignan production in a flaxseed intervention study in postmenopausal US women of African ancestry and European ancestry | |
| Andreu-Sánchez et al. | Global genetic diversity of human gut microbiome species is related to geographic location and host health | |
| Boolani et al. | Trait energy and fatigue may be connected to gut bacteria among young physically active adults: An exploratory study | |
| Peng et al. | The gut microbiota profile in children with Prader–Willi syndrome | |
| Lopez Leyva et al. | Human milk microbiome is shaped by breastfeeding practices | |
| He et al. | Treatment with mixed probiotics induced, enhanced and diversified modulation of the gut microbiome of healthy rats | |
| Pi et al. | Effects of different feeding methods on the structure, metabolism, and gas production of infant and toddler intestinal flora and their mechanisms | |
| Zhou et al. | Rumen and fecal microbiota characteristics of Qinchuan cattle with divergent residual feed intake | |
| US20240306691A1 (en) | Personalized Nutritional Supplements and Methods of Making | |
| Wang et al. | The multi-omics analysis revealed a metabolic regulatory system of cecum in rabbit with diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: VIOME LIFE SCIENCES, INC. Free format text: FORMER NAME(S): VIOME, INC. |